AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partnersto provide friendly and expert services. We provide world-class development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cell therapies. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba and Yokohama, Japan. Visit www.agcbio.com to learn more.
Looking for a particular AGC Biologics employee's phone or email?
AGC Biologics Questions
The AGC Biologics annual revenue was $843.9 million in 2026.
Mark Flower is the Vice President of Business Development, Cell and Gene Technologies of AGC Biologics.
2,201 people are employed at AGC Biologics.
AGC Biologics is based in Bothell, Washington.
Top AGC Biologics Employees
-
Jennifer Coe
VP, Corporate Controller (Global Finance) at AGC Biologics
Nashville, TN, US55+ -
Michael Tranmer
SVP and GM at AGC Biologics
Boulder, CO, US34 -
Tomoko Miyagawa
EVP Corporate Development at AGC Biologics
Kirkland, WA, US31 -
Martin Shawala
Senior Vice President at AGC Biologics
Kirkland, WA, US21 -
31
-
Jose Gonzalez
SVP General Manager at AGC Biologics
Teaneck, NJ, US52 -
Christian Christensen
Sr. Vice President at AGC Biologics
Copenhagen, DK33
Related Companies
